Movement Disorders·7 OctNeuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's DiseaseStudy in peoplePopulationsPaper
Journal of Parkinson's Disease·21 SepCognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug developmentReviewIndustry & policyPaper
Neuropsychology·10 SepUtilizing intraindividual cognitive variability to predict progression in stage 2 neuronal synuclein diseaseStudy in peopleBiomarkersPaper